These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
702 related articles for article (PubMed ID: 11161858)
21. Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma. Lianidou ES; Levesque MA; Katsaros D; Angelopoulou K; Yu H; Genta F; Arisio R; Massobrio M; Bharaj B; Diamandis EP Anticancer Res; 1999; 19(1B):749-56. PubMed ID: 10216487 [TBL] [Abstract][Full Text] [Related]
22. A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma. Righetti SC; Della Torre G; Pilotti S; Ménard S; Ottone F; Colnaghi MI; Pierotti MA; Lavarino C; Cornarotti M; Oriana S; Böhm S; Bresciani GL; Spatti G; Zunino F Cancer Res; 1996 Feb; 56(4):689-93. PubMed ID: 8630996 [TBL] [Abstract][Full Text] [Related]
23. [Detection and sequence analysis of the p53 gene mutation in epithelial ovarian cancer]. Guan X; Lang J; Bian M Zhonghua Fu Chan Ke Za Zhi; 1998 Mar; 33(3):165-7. PubMed ID: 10682487 [TBL] [Abstract][Full Text] [Related]
24. Alterations of p53 gene in primary gastric cancer tissues. Hong SI; Hong WS; Jang JJ; Lee DS; Cho NS; Jung ME; Kim HB; Ha GW; Park IC; Cho DS Anticancer Res; 1994; 14(3B):1251-5. PubMed ID: 8067692 [TBL] [Abstract][Full Text] [Related]
25. A frequent alteration of p53 gene in carcinoma in adenoma of colon. Ohue M; Tomita N; Monden T; Fujita M; Fukunaga M; Takami K; Yana I; Ohnishi T; Enomoto T; Inoue M Cancer Res; 1994 Sep; 54(17):4798-804. PubMed ID: 8062281 [TBL] [Abstract][Full Text] [Related]
26. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048 [TBL] [Abstract][Full Text] [Related]
27. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer. Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268 [TBL] [Abstract][Full Text] [Related]
28. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma. Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402 [TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of the BRCA1 tumor suppressor gene in endometrial carcinoma. Liu FS; Ho ES; Shih RT; Shih A Gynecol Oncol; 1997 Sep; 66(3):449-53. PubMed ID: 9299260 [TBL] [Abstract][Full Text] [Related]
30. Association of p53 mutations with metastatic prostate cancer. Eastham JA; Stapleton AM; Gousse AE; Timme TL; Yang G; Slawin KM; Wheeler TM; Scardino PT; Thompson TC Clin Cancer Res; 1995 Oct; 1(10):1111-8. PubMed ID: 9815901 [TBL] [Abstract][Full Text] [Related]
31. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis. de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838 [TBL] [Abstract][Full Text] [Related]
32. p53 alterations in chemically induced hamster cheek-pouch lesions. Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462 [TBL] [Abstract][Full Text] [Related]
33. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein. Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467 [TBL] [Abstract][Full Text] [Related]
34. Absence of p53 gene mutation and infrequent overexpression of p53 protein in hepatoblastoma. Chen TC; Hsieh LL; Kuo TT J Pathol; 1995 Jul; 176(3):243-7. PubMed ID: 7674087 [TBL] [Abstract][Full Text] [Related]
35. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors. Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974 [TBL] [Abstract][Full Text] [Related]
36. The role of p53 mutation in the carcinomas arising from endometriosis. Akahane T; Sekizawa A; Purwosunu Y; Nagatsuka M; Okai T Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423 [TBL] [Abstract][Full Text] [Related]
37. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120 [TBL] [Abstract][Full Text] [Related]
38. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024 [TBL] [Abstract][Full Text] [Related]
39. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033 [TBL] [Abstract][Full Text] [Related]
40. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors. Soong R; Iacopetta BJ Mod Pathol; 1997 Mar; 10(3):252-8. PubMed ID: 9071734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]